Reconstitution with Bcr-Abl negative recipient haematopoiesis after allogeneic BMT for CML

被引：0

作者：

Serrano, J ^{[1
]}

Román, J ^{[1
]}

Castillejo, JA ^{[1
]}

Navarro, JA ^{[1
]}

Pascual, A ^{[1
]}

García-Rubio, I ^{[1
]}

Falcón, M ^{[1
]}

Martín, C ^{[1
]}

Sánchez, J ^{[1
]}

Herrera, C ^{[1
]}

Torres, A ^{[1
]}

机构：

[1] Reina Sofia Hosp, Dept Haematol, Cordoba, Spain

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 1998年 / 102卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：318 / 318

页数：1

共 50 条

[31] The Impact Of Novel Splicing Abnormalities Of BCR-ABL On The Pathogenesis Of CML [J].

Yuda, Junichiro ;

Miyamoto, Toshihiro ;

Kikushige, Yoshikane ;

Odawara, Jun ;

Ohkawa, Yasuyuki ;

Akashi, Koichi .

BLOOD, 2013, 122 (21)

[32] Mutagenic analysis of bcr-abl in induction of CML in mice. [J].

Ren, RB ;

Zhang, XW .

BLOOD, 1997, 90 (10) :871-871

[33] Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML [J].

Druker, BJ .

ONCOGENE, 2002, 21 (56) :8541-8546

[34] Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML [J].

Carofiglio, Francesca ;

Lopalco, Antonio ;

Lopedota, Angela ;

Cutrignelli, Annalisa ;

Nicolotti, Orazio ;

Denora, Nunzio ;

Stefanachi, Angela ;

Leonetti, Francesco .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) :1-21

[35] BCR is a conditional negative regulator of BCR-ABL induced leukemias [J].

Arlinghaus, RB ;

Liu, J ;

Wu, Y ;

Ma, G ;

Lin, SH ;

Estrov, Z ;

Talpaz, M .

BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) :155-155

[36] BCR-ABL FUSION TRANSCRIPTS' FREQUENCIES IN SUDANESE CML PATIENTS [J].

Muddathir, AbdelRahim ;

Kordofani, Anwar ;

Fadl-Elmula, Imad .

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 :57-57

[37] STI571: Targeting BCR-ABL as therapy for CML [J].

Mauro, MJ ;

Druker, BJ .

ONCOLOGIST, 2001, 6 (03) :233-238

[38] Frequency of BCR-ABL Transcript Types in Syrian CML Patients [J].

Farhat-Maghribi, Sulaf ;

Habbal, Wafa ;

Monem, Fawza .

JOURNAL OF ONCOLOGY, 2016, 2016

[39] Analysis of mutations in the BCR-ABL TK domain in CML patients [J].

Nesslboeck, M. ;

Preuner, S. ;

Lion, T. .

KLINISCHE PADIATRIE, 2010, 222 (03) :217-217

[40] BCR-ABL targeted therapy in chronic myeloid leukemia (CML). [J].

Goldman, JM ;

Deininger, M ;

Melo, JV .

EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) :515-515

← 1 2 3 4 5 →